Pure Global
CDSCO UID IMP/IVD/2023/000392_b152e53819cfa5112d7f720c96757eac_6ebef34a05bd5e5f44da796f57f796f0

NAISSA EBV VCA IgG-"The test is intended for the quantitative detection of IgG/IgM antibodies to Epstein

M/s Vishat Diagnostic Pvt Ltd.·Device Class Class B·India CDSCO
Registration details
UID
IMP/IVD/2023/000392_b152e53819cfa5112d7f720c96757eac_6ebef34a05bd5e5f44da796f57f796f0
Device class
Class B
License holder
M/s Vishat Diagnostic Pvt Ltd.
Approving authority
CDSCO
Product information
Barr virus viral capsid antigen in human serum or plasma."
Other products from M/s Vishat Diagnostic Pvt Ltd.
Products from the same license holder (10 products)
Anti-dsDNA IgG
Class B
DHEA
Brand: E1
Class B
AMH
Class B
Anti-SS-B
Class B
Ferritin
Class B
NAISSA System liquid
Class B
NAISSA RSV IgM
Class B
Anti-SS-A
Class B
CCP IgG
Class B
PTH
Class B
About this record

NAISSA EBV VCA IgG-"The test is intended for the quantitative detection of IgG/IgM antibodies to Epstein is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000392_b152e53819cfa5112d7f720c96757eac_6ebef34a05bd5e5f44da796f57f796f0. The license holder is M/s Vishat Diagnostic Pvt Ltd., and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.